Lumexa Imaging Holdings, Inc. Common Stock (LMRI) is a publicly traded the market company. As of November 10, 2026, LMRI trades at $14.18 with a market cap of $1.34B and a P/E ratio of 355.33. LMRI moved -0.14% today. Year to date, LMRI is -20.54%; over the trailing twelve months it is flat. Its 52-week range spans $6.45 to $19.45. Analyst consensus is strong buy with an average price target of $17.00. Rallies surfaces LMRI's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for LMRI shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $14.18 |
| Market Cap | $1.34B |
| P/E Ratio | 355.33 |
| EPS | $0.03 |
| Dividend Yield | 0.00% |
| 52-Week High | $19.45 |
| 52-Week Low | $6.45 |
| Volume | 344.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $264.16M |
| Net Income | $2.75M |
| Gross Margin | 0.00% |
8 analysts cover LMRI: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $17.00.